Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Farmers Insurance
Covington
QuintilesIMS
US Army
Dow
Citi
Daiichi Sankyo

Generated: June 19, 2018

DrugPatentWatch Database Preview

CLARITHROMYCIN - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for clarithromycin and what is the scope of clarithromycin patent protection?

Clarithromycin
is the generic ingredient in three branded drugs marketed by Abbvie, Sandoz, Sun Pharm Inds Ltd, Actavis Labs Fl Inc, Allied Pharma Inc, Ani Pharms Inc, Lupin Ltd, Mayne Pharma, Ranbaxy, Apotex Corp, Aurobindo, Hec Pharm Usa Inc, Ivax Sub Teva Pharms, Mylan, Teva, West-ward Pharms Int, and Wockhardt, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for clarithromycin. Thirty-seven suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for CLARITHROMYCIN
Synonyms for CLARITHROMYCIN
(14R)-14-Hydroxyclarithromycin
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl
103C119
6-0-methylerythromycin A
6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
6-O-methyl erythromycin
6-O-Methyl-erythromycin
6-O-Methylerythromycin
6-O-Methylerythromycin a
81103-11-9
A-56268
AB00053394_14
AB00053394_15
AB00053394-10
AB00053394-12
AB00053394-13
Abbotic
Abbott-56268
AC1L36NJ
Adel
AGOYDEPGAOXOCK-KCBOHYOISA-N
AKOS015894242
ANX-015
Astromen
BB_NC-1450
BDBM50404044
Biaxin
Biaxin (TN)
Biaxin filmtab
Biaxin HP
Biaxin XL
Biaxin xl filmtab
Bicrolid
BIDD:GT0200
BSPBio_003453
C-23486
C06912
C30H54O11.C9H19NO2
C38H69NO13
CA011954
CC-25899
CCG-39086
CCRIS 8833
CHEBI:3732
CHEMBL1741
CHEMBL3764720
CLA;
Clacee
Clacid
Clacine
Clambiotic
clamicin
Clarem
Clari
Claribid
Claricide
Claridar
Claripen
Clarith
Clarithromycin (Biaxin, Klacid)
Clarithromycin (JP17/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin [USAN:USP:INN:BAN:JAN]
Clarithromycin & Interleukin-12
Clarithromycin extended release
Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
Clarithromycin Identity, United States Pharmacopeia (USP) Reference Standard
Clarithromycin suspension or tablets
Clarithromycin, >=95% (HPLC)
Clarithromycin, >=98% (HPLC)
Clarithromycin, European Pharmacopoeia (EP) Reference Standard
Clarithromycin, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Clarithromycin, Ready Made Solution, 50 mg/mL in DMSO, 0.2 mum filtered
Clarithromycin, United States Pharmacopeia (USP) Reference Standard
clarithromycina
Clarithromycine
Clarithromycine [INN-French]
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
CLM & IL-12
CPD000466382
Crixan
CS-2576
CTY
Cyllid
Cyllind
D00276
DB01211
DivK1c_006655
DR003526
DRG-0099
DTXSID3022829
EBD13493
Erythromycin, 6-O-methyl-
ERYTHROMYCIN,14-HYDROXY-6-O-METHYL-, (14R)-
Fromilid
FT-0602940
H1250JIK0A
H781
Helas
Heliclar
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
HMS2231A08
HSDB 8055
HY-17508
Infex
J10130
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klabax
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
LMPK04000014
LS-1812
Mabicrol
Macladin
Maclar
Mavid
MCULE-7168853332
MFCD00865140
MLS000759516
MLS001201751
MLS001424066
MolPort-002-507-425
Naxy
NC00140
NCGC00178054-01
NSC-758704
NSC758704
O(6)-methylerythromycin
Pharmakon1600-01504231
Q-200870
s2555
SAM001246748
SBI-0206716.P001
SCHEMBL38125
SDP-015
SMR000466382
SPBio_001855
SpecPlus_000559
Spectrum_000089
SPECTRUM1504231
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
TE-031
TE031
UNII-H1250JIK0A
Veclam
Vikrol
Zeclar
ZINC85534098

US Patents and Regulatory Information for CLARITHROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie BIAXIN clarithromycin TABLET;ORAL 050662-001 Oct 31, 1991 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int CLARITHROMYCIN clarithromycin TABLET;ORAL 065178-001 May 25, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan CLARITHROMYCIN clarithromycin TABLET;ORAL 065195-001 Mar 11, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt CLARITHROMYCIN clarithromycin TABLET;ORAL 065266-001 May 31, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for CLARITHROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie BIAXIN XL clarithromycin TABLET, EXTENDED RELEASE;ORAL 050775-001 Mar 3, 2000 ➤ Sign Up ➤ Sign Up
Abbvie BIAXIN XL clarithromycin TABLET, EXTENDED RELEASE;ORAL 050775-001 Mar 3, 2000 ➤ Sign Up ➤ Sign Up
Abbvie BIAXIN XL clarithromycin TABLET, EXTENDED RELEASE;ORAL 050775-001 Mar 3, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Farmers Insurance
UBS
Queensland Health
AstraZeneca
US Department of Justice
Merck
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.